Literature DB >> 33364192

Radiomics Feature Activation Maps as a New Tool for Signature Interpretability.

Diem Vuong1, Stephanie Tanadini-Lang1, Ze Wu1, Robert Marks1, Jan Unkelbach1, Sven Hillinger2, Eric Innocents Eboulet3, Sandra Thierstein3, Solange Peters4, Miklos Pless5, Matthias Guckenberger1, Marta Bogowicz1.   

Abstract

INTRODUCTION: In the field of personalized medicine, radiomics has shown its potential to support treatment decisions. However, the limited feature interpretability hampers its introduction into the clinics. Here, we propose a new methodology to create radiomics feature activation maps, which allows to identify the spatial-anatomical locations responsible for signature activation based on local radiomics. The feasibility of this technique will be studied for histological subtype differentiation (adenocarcinoma versus squamous cell carcinoma) in non-small cell lung cancer (NSCLC) using computed tomography (CT) radiomics.
MATERIALS AND METHODS: Pre-treatment CT scans were collected from a multi-centric Swiss trial (training, n=73, IIIA/N2 NSCLC, SAKK 16/00) and an independent cohort (validation, n=32, IIIA/N2/IIIB NSCLC). Based on the gross tumor volume (GTV), four peritumoral region of interests (ROI) were defined: lung_exterior (expansion into the lung), iso_exterior (expansion into lung and soft tissue), gradient (GTV border region), GTV+Rim (GTV and iso_exterior). For each ROI, 154 radiomic features were extracted using an in-house developed software implementation (Z-Rad, Python v2.7.14). Features robust against delineation variability served as an input for a multivariate logistic regression analysis. Model performance was quantified using the area under the receiver operating characteristic curve (AUC) and verified using five-fold cross validation and internal validation. Local radiomic features were extracted from the GTV+Rim ROI using non-overlapping 3x3x3 voxel patches previously marked as GTV or rim. A binary activation map was created for each patient using the median global feature value from the training. The ratios of activated/non-activated patches of GTV and rim regions were compared between histological subtypes (Wilcoxon test).
RESULTS: Iso_exterior, gradient, GTV+Rim showed good performances for histological subtype prediction (AUCtraining=0.68-0.72 and AUCvalidation=0.73-0.74) whereas GTV and lung_exterior models failed validation. GTV+Rim model feature activation maps showed that local texture feature distribution differed significantly between histological subtypes in the rim (p=0.0481) but not in the GTV (p=0.461).
CONCLUSION: In this exploratory study, radiomics-based prediction of NSCLC histological subtypes was predominantly based on the peritumoral region indicating that radiomics activation maps can be useful for tracing back the spatial location of regions responsible for signature activation.
Copyright © 2020 Vuong, Tanadini-Lang, Wu, Marks, Unkelbach, Hillinger, Eboulet, Thierstein, Peters, Pless, Guckenberger and Bogowicz.

Entities:  

Keywords:  computed tomography; interpretability; local radiomics; lung cancer; peritumoral radiomics; radiomics activation maps

Year:  2020        PMID: 33364192      PMCID: PMC7753181          DOI: 10.3389/fonc.2020.578895

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  42 in total

1.  Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.

Authors:  Marta Bogowicz; Oliver Riesterer; Kristian Ikenberg; Sonja Stieb; Holger Moch; Gabriela Studer; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-06-15       Impact factor: 7.038

2.  Influence of inter-observer delineation variability on radiomics stability in different tumor sites.

Authors:  Matea Pavic; Marta Bogowicz; Xaver Würms; Stefan Glatz; Tobias Finazzi; Oliver Riesterer; Johannes Roesch; Leonie Rudofsky; Martina Friess; Patrick Veit-Haibach; Martin Huellner; Isabelle Opitz; Walter Weder; Thomas Frauenfelder; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Acta Oncol       Date:  2018-03-07       Impact factor: 4.089

3.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.

Authors:  Yanqi Huang; Zaiyi Liu; Lan He; Xin Chen; Dan Pan; Zelan Ma; Cuishan Liang; Jie Tian; Changhong Liang
Journal:  Radiology       Date:  2016-06-27       Impact factor: 11.105

Review 4.  Non-small-cell lung cancers: a heterogeneous set of diseases.

Authors:  Zhao Chen; Christine M Fillmore; Peter S Hammerman; Carla F Kim; Kwok-Kin Wong
Journal:  Nat Rev Cancer       Date:  2014-08       Impact factor: 60.716

5.  Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patients.

Authors:  Diem Vuong; Marta Bogowicz; Sarah Denzler; Carol Oliveira; Robert Foerster; Florian Amstutz; Hubert S Gabryś; Jan Unkelbach; Sven Hillinger; Sandra Thierstein; Alexandros Xyrafas; Solange Peters; Miklos Pless; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Med Phys       Date:  2020-07-13       Impact factor: 4.071

6.  Harmonizing the pixel size in retrospective computed tomography radiomics studies.

Authors:  Dennis Mackin; Xenia Fave; Lifei Zhang; Jinzhong Yang; A Kyle Jones; Chaan S Ng; Laurence Court
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

7.  The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.

Authors:  Alex Zwanenburg; Martin Vallières; Mahmoud A Abdalah; Hugo J W L Aerts; Vincent Andrearczyk; Aditya Apte; Saeed Ashrafinia; Spyridon Bakas; Roelof J Beukinga; Ronald Boellaard; Marta Bogowicz; Luca Boldrini; Irène Buvat; Gary J R Cook; Christos Davatzikos; Adrien Depeursinge; Marie-Charlotte Desseroit; Nicola Dinapoli; Cuong Viet Dinh; Sebastian Echegaray; Issam El Naqa; Andriy Y Fedorov; Roberto Gatta; Robert J Gillies; Vicky Goh; Michael Götz; Matthias Guckenberger; Sung Min Ha; Mathieu Hatt; Fabian Isensee; Philippe Lambin; Stefan Leger; Ralph T H Leijenaar; Jacopo Lenkowicz; Fiona Lippert; Are Losnegård; Klaus H Maier-Hein; Olivier Morin; Henning Müller; Sandy Napel; Christophe Nioche; Fanny Orlhac; Sarthak Pati; Elisabeth A G Pfaehler; Arman Rahmim; Arvind U K Rao; Jonas Scherer; Muhammad Musib Siddique; Nanna M Sijtsema; Jairo Socarras Fernandez; Emiliano Spezi; Roel J H M Steenbakkers; Stephanie Tanadini-Lang; Daniela Thorwarth; Esther G C Troost; Taman Upadhaya; Vincenzo Valentini; Lisanne V van Dijk; Joost van Griethuysen; Floris H P van Velden; Philip Whybra; Christian Richter; Steffen Löck
Journal:  Radiology       Date:  2020-03-10       Impact factor: 29.146

8.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

9.  Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology.

Authors:  Weimiao Wu; Chintan Parmar; Patrick Grossmann; John Quackenbush; Philippe Lambin; Johan Bussink; Raymond Mak; Hugo J W L Aerts
Journal:  Front Oncol       Date:  2016-03-30       Impact factor: 6.244

10.  Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?

Authors:  Subba R Digumarthy; Atul M Padole; Roberto Lo Gullo; Lecia V Sequist; Mannudeep K Kalra
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

View more
  7 in total

1.  Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.

Authors:  Anna-Katharina Meißner; Robin Gutsche; Norbert Galldiks; Martin Kocher; Stephanie T Jünger; Marie-Lisa Eich; Manuel Montesinos-Rongen; Anna Brunn; Martina Deckert; Christina Wendl; Wolfgang Dietmaier; Roland Goldbrunner; Maximilian I Ruge; Cornelia Mauch; Nils-Ole Schmidt; Martin Proescholdt; Stefan Grau; Philipp Lohmann
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

2.  Context-Aware Saliency Guided Radiomics: Application to Prediction of Outcome and HPV-Status from Multi-Center PET/CT Images of Head and Neck Cancer.

Authors:  Wenbing Lv; Hui Xu; Xu Han; Hao Zhang; Jianhua Ma; Arman Rahmim; Lijun Lu
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

3.  Development and External Validation of a Simple-To-Use Dynamic Nomogram for Predicting Breast Malignancy Based on Ultrasound Morphometric Features: A Retrospective Multicenter Study.

Authors:  Qingling Zhang; Qinglu Zhang; Taixia Liu; Tingting Bao; Qingqing Li; You Yang
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

4.  Voxel-wise supervised analysis of tumors with multimodal engineered features to highlight interpretable biological patterns.

Authors:  Thibault Escobar; Sébastien Vauclin; Fanny Orlhac; Christophe Nioche; Pascal Pineau; Laurence Champion; Hervé Brisse; Irène Buvat
Journal:  Med Phys       Date:  2022-04-21       Impact factor: 4.506

5.  Usefulness of MRI-based radiomic features for distinguishing Warthin tumor from pleomorphic adenoma: performance assessment using T2-weighted and post-contrast T1-weighted MR images.

Authors:  Lorenzo Faggioni; Michela Gabelloni; Fabrizio De Vietro; Jessica Frey; Vincenzo Mendola; Diletta Cavallero; Rita Borgheresi; Lorenzo Tumminello; Jorge Shortrede; Riccardo Morganti; Veronica Seccia; Francesca Coppola; Dania Cioni; Emanuele Neri
Journal:  Eur J Radiol Open       Date:  2022-06-18

Review 6.  The Potential and Emerging Role of Quantitative Imaging Biomarkers for Cancer Characterization.

Authors:  Hishan Tharmaseelan; Alexander Hertel; Shereen Rennebaum; Dominik Nörenberg; Verena Haselmann; Stefan O Schoenberg; Matthias F Froelich
Journal:  Cancers (Basel)       Date:  2022-07-09       Impact factor: 6.575

7.  The value of combined PET/MRI, CT and clinical metabolic parameters in differentiating lung adenocarcinoma from squamous cell carcinoma.

Authors:  Xin Tang; Jiaojiao Wu; Jiangtao Liang; Changfeng Yuan; Feng Shi; Zhongxiang Ding
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.